Second-line protease inhibitor-based highly active antiretroviral therapy after failing non-nucleoside reverse transcriptase inhibitors-based regimens in Asian HIV-infected children

BACKGROUND: The WHO recommends boosted protease inhibitor (bPI)-based highly active antiretroviral therapy (HAART) after failing non-nucleoside reverse transcriptase inhibitor (NNRTI) treatment. We examined outcomes of this regimen in Asian HIV-infected children. METHODS: Children from five Asian co...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Bunupuradah, Torsak, Puthanakit, Thanyawee, Fahey, Paul, Kariminia, Azar, Yusoff, Nik Khairulddin Nik, Khanh, Truong Huu, Sohn, Annette H., Chokephaibulkit, Kulkanya, Lumbiganon, Pagakrong, Hansudewechakul, Rawiwan, Razali, Kamarul, Kurniati, Nia, Huy, Bui Vu, Sudjaritruk, Tavitiya, Kumarasamy, Nagalingeswaran, Fong, Siew Moy, Saphonn, Vonthanak, Ananworanich, Jintanat
التنسيق: Artigo
اللغة:Inglês
منشور في: 2013
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715593/
https://ncbi.nlm.nih.gov/pubmed/23296119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2494
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة